Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results

Dicerna Pharmaceuticals Inc (DRNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2020 GN VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
02/05/2019 GN Recent Analysis Shows DICK'S Sporting Goods, Zix, Q2, InfraREIT, The Boston Beer, and Dicerna Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth
11/30/2018 GN Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture — Research Highlights Growth, Revenue, and Consolidated Results
08/29/2018 GN Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications
07/25/2018 GN Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals — Future Expectations, Projections Moving into 2018
05/18/2018 GN Research Report Identifies Carolina Financial, Dicerna Pharmaceuticals, On Assignment, Digimarc, CIRCOR International, and Nordson with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
05/14/2018 BW Dicerna Reports First Quarter 2018 Financial and Operating Results and Provides Corporate Update
05/07/2018 BW Dicerna to Report First Quarter 2018 Financial Results and Host Conference Call on May 14, 2018
03/08/2018 BW Dicerna Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update
03/01/2018 BW Dicerna to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on March 8, 2018
01/24/2018 GN Analysis: Positioning to Benefit within Ferroglobe, Corbus Pharmaceuticals, Meritage, Dicerna Pharmaceuticals, Castle Brands, and Ply Gem — Research Highlights Growth, Revenue, and Consolidated Results
11/02/2017 BW Dicerna Reports Third Quarter 2017 Financial and Operating Results and Provides Corporate Update
10/26/2017 BW Dicerna to Report Third Quarter 2017 Financial Results and Host Conference Call on November 2, 2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy